U.S to Invest in Smallpox Vaccine

Last month the U.S Department of Health and Human Services invested in a plant to manufacture flue vaccine in case of an epidemic. Now SIGA Technologies reports that the Department has released a presolicitation for buying 1.7 million treatment courses for smallpox. MSNBC discusses this story here. SIGA Technologies is developing an antiviral drug to counter smallpox and the company feels they are should be able to propose when the RFP is eventually released. The contract could end up being for 12 million doses. There has always been concern of biological terrorist attack and the U.S. government continues to invest in counters for this.